The FOPH shall collect data on medical treatments using narcotics containing an effective concentration of cannabis (medicinal cannabis products) that:
are not authorised;
are authorised but are prescribed for an indication other than the authorised indication and used in a form other than the authorised pharmaceutical form.
The data is collected for:
the scientific evaluation under Article 29a ; and
statistical analysis.
The FOPH shall make the results of the statistical analysis available to:
the cantonal executive authorities;
the doctors involved in the treatment;
research institutions that are interested.
0 commentaries
No commentaries are available for this article yet.